← Open Payments lookup

LAVON LANDIS: Open Payments

NPI 1508436817 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$553 in 23 payments from 12 companies in 2025. Trend: 2023 $1,753 · 2024 $1,089 · 2025 $553

Food & beverage: $553
CompanyPaymentsAmount
ABBVIE INC.5$103
Otsuka America Pharmaceutical, Inc.1$89
Supernus Pharmaceuticals, Inc.4$77
Vanda Pharmaceuticals Inc.2$58
E.R. Squibb & Sons, L.L.C.2$48
Neurocrine BioSciences, Inc.2$41
Lundbeck LLC2$41
IDORSIA PHARMACEUTICALS US INC1$21
Takeda Pharmaceuticals U.S.A., Inc.1$20
Soleno Therapeutics, Inc.1$20

Products named: REXULTI, VRAYLAR, Qelbree, COBENFY, INGREZZA, HETLIOZ, FANAPT, Quviviq.

Industry payments across MD — which companies pay providers there.